COMPARISON OF EFFICACY OF INTRALESIONAL TRIAMCINOLONE ACETONIDE VERSUS COMBINATION OF INTRALESIONAL TRIAMCINOLONE WITH 5-FLUOROURACIL IN TREATMENT OF KELOIDS: A RANDOMIZED CONTROLLED TRIAL
Article Sidebar
Main Article Content
Abstract
Objective: To determine the efficacy of conventionally used Triamcinolone Acetonide (TCA) in the treatment of keloids versus its combination with 5 fluorouracil (FU).
Methodology: In this randomized control trial, 60 patients were included 30 in each group. A combination of triamcinolone and 5-FU was given to Group-A while Group B was administered intralesional triamcinolone in combination with 5 FU. The Efficacy was deemed as positive if post-treatment was a more than 70 % reduction in Patient and Observer Scar Assessment Scale (POSAS) from baseline.
Results: Mean age of the patients was 33.6±8.8 and 32.1±8.8 years in group-A and B, respectively. There were 12 males (40%) in group-A and 14 (46.7%) in group B. Females were 18 (60%) in group-A while 16 (53.3%) were in group B. Most of the patients were having Fitzpatrick skin type 4 in both groups. Efficacy was found to be 28 (93.3%) in group-A and 19 (63.3%) in group B (p=0.005). Stratification for age, gender, and Fitzpatrick skin type was also carried out.
Conclusion: This study concluded that the intralesional TCA was effective in 63.3% and a combination of intralesional 5-FU and TCA was effective in 93.3% of cases of keloids. This difference in efficacy is statistically significant (p=0.005).
Article Details
Work published in JPMI is licensed under a
Creative Commons Attribution-NonCommercial 2.0 Generic License.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
References
Maghrabi IB. Kabel AM. Management of keloid and hypertrophic scars: a of nutrition, drugs. cryotherapy and phototherapy. J Nutr Heal. 2014;2:28-32.
Afshan S. Atif S, Ijaz H. Comparison of efficacy of intralesional 5-fluorouracil one versus intralesional triamcinolone acetonide with 5-fluorouracil in small keloids. 2016;26:361-5.
Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG. Hypertrophic scarring and keloids: Pathomechanisms and current and emerging treatment strategies. Mol Med. 2011;17:113-25. DOI:10.2119/molmed.2009.00153.
Ogawa R. The most current algorithms for the treatment and prevention of hypertrophic scars and keloids. Plast Reconstr Surg. 2010;125:557-68.
DOI:10.1097/PRS.0b013e3181c82dd5.
Muneuchi G, Suzuki S, Onodera M, Ito 0, Hata Y, Igawa HH. Longterm outcome of intralesional injection of 86 triamcinolone acetonide for the treatment of keloid scars in Asian patients. Scand J Plast Reconstr Surg Hand Surg. 2006:40:111-6. DOI:10.1080/02844310500430003.
Bij lard F. Steltenpool S, Niessen FB. Intralesional 5- fluorouracil in keloid treatment: systematic review. Acta Derm Venereal. 2015:95:778-82. DOI:10.2340/00015555-2106.
Davison SP, Dayan JH, Clemens W, Wang SSA, Crane A. Efficacy of intralesional 5-fluorouracil and triamcinolone in the treatment of keloids. Aesthetic Surgery J. 2009; 29:46. DOI:10.1016/j.asj.2008.11.006.
Saleem F, Rani Z, Bashir B, Altaf F, Khurshid K, Pal SS. Comparison of efficacy of intralesional 5-fluorouracil plus triamcinolone acetonide versus intralesional triamcinolone acetonide in the treatment of keloids. J Pak Assoc Dermatol. 2017;27:114-9.
Khan MA, Bashir MM, Khan FA. Intralesional triamcinolone alone and in combination with 5-fluorouracil for the treatment of keloid and hypertrophic scars. J Pak Med Assoc. 2014;64:1003-7.
Sharma S, Bassi R, Gupta A. Treatment of small keloids 87 with intralesional 5fluorouracil alone vs. intralesional triamcinolone acetonide with 5-fluorouracil. J Pak Assoc Dermatol. 2012; 22:35-40.
Prabhu A, Sreekar H, Powar R, Uppin V. A randomized controlled trial comparing the efficacy of intralesional 5- fluorouracil versus triamcinolone acetonide in the treatment of keloids. J Sci Soc. 2012;39:19.
Gauglitz GG. Management of of keloids and hypertrophic scars: current and emerging options. J Clin Cosmet Investig Dermatol. 2013;6:103-14. DOI:10.2147/CCID.S35252.
Robles DT, Berg D. Abnormal wound healing: keloids. Clin Dermatol. 2007;25:26–32. DOI:10.1016/j.clindermatol.2006.09.009.
Durani P, Bayat A. Levels of evidence for the treatment of keloid disease. J Plast Reconstr Aesthet Surg. 2008;61:4–17. DOI:10.1016/j.bjps.2007.05.007.
Fraccalvieri M, Bogetti P, Salomone M, Di Santo C, Ruka E, Bruschi S. Cryotreatment of keloids: a single Italian institution experience. Eur J Plast Surg. 2016;39:201–6. DOI:10.1007/s00238-015-1170-6.
van Leeuwen MCE, van der Wal MBA, Bulstra AJ, Galindo Garre F, Molier J, van Zuijlen PPM, et al. Intralesional cryotherapy for treatment of keloid scars: a prospective study. Plast Reconstr Surg. 2015;135(2):580-9. DOI:10.1097/PRS.0000000000000911.
Sherris DA, Larrabee WF, Jr, Murakami CS. Management of scar contractures, hypertrophic scars, and keloids. Otolaryngol Clin N Am. 1995;28:1057–68.
Hochman B, Locali RF, Matsuoka PK. Intralesional triamcinolone acetonide for keloid treatment: a systematic review. Aesthetic Plast Surg. 2008;32:705–9. DOI:10.1007/s00266-008-9152-8.
Leventhal D, Furr M, Reiter D. Treatment of keloids and hypertrophic scars: a meta-analysis and review of the literature. Arch Facial Plast Surg. 2006;8:362–8. DOI:10.1001/archfaci.8.6.362.
Roques C, Téot L. The use of corticosteroids to treat keloids: a review. Int J Low Extrem Wounds. 2008;7(3):137-45. DOI:10.1177/1534734608320786.
Campaner AB, Ferreira LM, Gragnani A, Bruder JM, Cusick JL, Morgan JR. Upregulation of TGF-beta1 expression may be necessary but is not sufficient for excessive scarring. J Invest Dermatol. 2006;126:1168–76. DOI:10.1038/sj.jid.5700200.
Lee SS, Yosipovitch G, Chan YH, Goh CL. Pruritus, pain, and small nerve fiber function in keloids: a controlled study. J Am Acad Dermatol. 2004;51:1002–6. DOI:10.1016/s1085-5629(99)80040-6.
Urioste SS, Arndt KA, Dover JS. Keloids and hypertrophic scars: review and treatment strategies. Semin Cutan Med Surg. 1999;18:159–71. DOI:10.1016/s1085-5629(99)80040-6.
Bulstrode NW, Mudera V, McGrouther DA, Grobbelaar AO, Cambrey AD. 5-fluorouracil selectively inhibits collagen synthesis. Plast Reconstr Surg. 2005;116(1):209-21;discussion 222-3. DOI:10.1097/01.prs.0000169701.16509.d6.
Ghoshal K, Jacob ST. An alternative molecular mechanism of action of 5-fluorouracil, a potent anticancer drug. Biochem Pharmacol. 1997;53:1569–75. DOI:10.1016/s0006-2952(97)00040-3.
Bijlard E, Steltenpool S, Niessen FB. Intralesional 5- 115 fluorouracil in keloid treatment: a systematic review. Acta Derm Venereol. 2015;95:778–82. DOI:10.2340/00015555-2106.
Huang L, Cai YJ, Lung I, Leung BC, Burd A. A study of the combination of triamcinolone and 5-fluorouracil in modulating keloid fibroblasts in vitro. J Plast Reconstr Aesthet Surg. 2013;66:e251–e259. DOI:10.1016/j.bjps.2013.06.004.
Gupta S, Kalra A. Efficacy and safety of intralesional 5- fluorouracil in the treatment of keloids. Dermatology. 2002;204:130–32. DOI:10.1159/000051830.
Manuskiatti W, Fitzpatrick RE. Treatment response of keloidal and hypertrophic sternotomy scars: comparison among intralesional corticosteroid, 5-fluorouracil, and 585- nm flashlamp-pumped pulsed-dye laser treatments. Arch Dermatol. 2002;138:1149–55. DOI:10.1001/archderm.138.9.1149.
Darougheh A, Asilian A, Shariati F. Intralesional triamcinolone alone or in combination with 5-fluorouracil for the treatment of keloid and hypertrophic scars. Clin Exp Dermatol. 2009; 34:219–23. DOI:10.1111/j.1365-2230.2007.02631.x
Nagarur K, Raja N. A comparative study between intralesional 5-fluorouracil combined with triamcinolone acetonide and triamcinolone acetonide alone in the treatment of keloids. Int J Basic Clin Pharmacol. 2016;5:1090–8. DOI:10.18203/2319-2003.ijbcp20161574
Ren Y, Zhou X, Wei Z, Lin W, Fan B, Feng S. Efficacy and safety of triamcinolone acetonide alone and in combination with 5- fluorouracil for treating hypertrophic scars and keloids: a systematic review and meta-analysis. Int Wound J. 2016;14:480–7. DOI:10.1111/iwj.12629.
Zhang ZY. Therapy function of 5-Fu associate with steroid to keloid (Medical Science). J Tongji Univ. 2007;28:79–82.
Harinatha S, Raghunath N, Reddy R, Hebbar A, Harinatha S. Keloid and hypertrophic scar distribution according to fitzpatrick skin phototypes in Indian population- an hospital based study. Rev Soc Bras Cir Plást. 2014;29(2):309-10. DOI: 10.5935/2177-1235.2014rbcp0057